Companies / HCA Healthcare, Inc. / Activity
Activity — HCA Healthcare, Inc.
66 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | Hazen Samuel N CEO | Other | Common Stock | $20.25M | -41K -35.57% | 75,153 0.03% of shares | low |
| Feb 10, 2026 | Hazen Samuel N CEO | Other | Common Stock | $10.71M | -21K -24.75% | 64,842 0.03% of shares | low |
| Feb 5, 2026 | Foster Jon M Executive | Other | Common Stock | $8.26M | -16K -54.81% | 13,254 <0.01% of shares | low |
| Feb 3, 2026 | Hazen Samuel N CEO | Sell | Common Stock | $7.40M | -15K -19.58% | 60,437 0.03% of shares | medium |
| Jan 30, 2026 | Hazen Samuel N CEO | Exercise | Common Stock | $6.91M | +84K +261.37% | 116,636 0.05% of shares | low |
| Feb 5, 2026 | Foster Jon M Executive | Exercise | Common Stock | $4.08M | +29K | 29,330 0.01% of shares | low |
| Feb 3, 2026 | Hazen Samuel N CEO | Sell | Common Stock | $3.70M | -7K -13.34% | 48,040 0.02% of shares | medium |
| Feb 3, 2026 | Hazen Samuel N CEO | Sell | Common Stock | $3.09M | -6K -12.88% | 41,851 0.02% of shares | medium |
| Feb 10, 2026 | Foster Jon M Executive | Other | Common Stock | $2.96M | -6K -20.34% | 23,062 0.01% of shares | low |
| Feb 5, 2026 | Wyatt Christopher F. Executive | Other | Common Stock | $2.92M | -6K -10.97% | 46,063 0.02% of shares | low |
| Feb 3, 2026 | Hazen Samuel N CEO | Sell | Common Stock | $2.57M | -5K -12.33% | 36,689 0.02% of shares | medium |
| Feb 3, 2026 | Hazen Samuel N CEO | Sell | Common Stock | $2.51M | -5K -8.28% | 55,435 0.03% of shares | medium |
| Feb 3, 2026 | Hazen Samuel N CEO | Sell | Common Stock | $2.14M | -4K -11.70% | 32,396 0.01% of shares | medium |
| Feb 11, 2026 | Berres Jennifer Executive | Sell | Common Stock | $2.11M | -4K -25.06% | 11,993 <0.01% of shares | medium |
| Feb 11, 2026 | Wyatt Christopher F. Executive | Sell | Common Stock | $2.02M | -4K -8.27% | 44,379 0.02% of shares | medium |
| Feb 11, 2026 | Berres Jennifer Executive | Sell | Common Stock | $2.02M | -4K -20.04% | 16,003 <0.01% of shares | medium |
| Feb 13, 2026 | McAlevey Michael R Executive | Other | Common Stock | $1.79M | -3K -23.86% | 10,547 <0.01% of shares | low |
| Feb 10, 2026 | Cuffe Michael S. Executive | Other | Common Stock | $1.76M | -4K -9.84% | 32,080 0.01% of shares | low |
| Feb 10, 2026 | McAlevey Michael R Executive | Other | Common Stock | $1.51M | -3K -25.35% | 8,853 <0.01% of shares | low |
| Feb 5, 2026 | Wyatt Christopher F. Executive | Exercise | Common Stock | $1.48M | +11K +25.98% | 51,737 0.02% of shares | low |
| Feb 10, 2026 | Berres Jennifer Executive | Other | Common Stock | $1.26M | -3K -11.16% | 20,013 <0.01% of shares | low |
| Feb 13, 2026 | McAlevey Michael R Executive | Exercise | Common Stock | $1.18M | +5K +56.48% | 13,853 <0.01% of shares | low |
| Feb 18, 2026 | McAlevey Michael R Executive | Sell | Common Stock | $903.5K | -2K -16.06% | 8,853 <0.01% of shares | medium |
| Feb 10, 2026 | Marks Mike A Executive | Other | Common Stock | $848.5K | -2K -33.63% | 3,336 <0.01% of shares | low |
| Feb 3, 2026 | Cuffe Michael S. Executive | Sell | Common Stock | $747.1K | -2K -4.76% | 30,003 0.01% of shares | medium |
| Feb 4, 2026 | Hazen Samuel N CEO | Other | Common Stock | $520.8K | +1K +6.98% | 16,024 <0.01% of shares | low |
| Feb 4, 2026 | Hazen Samuel N CEO | Other | Common Stock | $520.8K | -1K -3.24% | 31,231 0.01% of shares | low |
| Feb 10, 2026 | Wyatt Christopher F. Executive | Other | Common Stock | $519.1K | -1K -2.09% | 48,379 0.02% of shares | low |
| Feb 10, 2026 | Rossitto Erica Executive | Other | Common Stock | $209.9K | -418 -3.86% | 10,407 <0.01% of shares | low |
| Feb 3, 2026 | Hazen Samuel N CEO | Sell | Common Stock | $59.7K | -120 -0.37% | 32,276 0.01% of shares | low |
| Apr 28, 2026 | Johnston Hugh F Director | Grant | Common Stock | $0 | +809 +22.07% | 4,475 <0.01% of shares | low |
| Apr 28, 2026 | Frist Thomas F III Director | Grant | Common Stock, par value $0.01 per share | $0 | +1K +7.03% | 15,858 <0.01% of shares | low |
| Apr 28, 2026 | Michelson Michael W Director | Grant | Common Stock | $0 | +925 +7.94% | 12,576 <0.01% of shares | low |
| Apr 28, 2026 | Deparle Nancy Ann Director | Grant | Common Stock | $0 | +509 +2.38% | 21,910 0.01% of shares | low |
| Apr 28, 2026 | Chidsey John Director | Grant | Common Stock | $0 | +809 +163.10% | 1,305 <0.01% of shares | low |
| Feb 10, 2026 | Rossitto Erica Executive | Grant | Common Stock | $0 | +2K +18.32% | 10,825 <0.01% of shares | low |
| Feb 10, 2026 | Marks Mike A Executive | Grant | Common Stock | $0 | +5K | 5,026 <0.01% of shares | low |
| Feb 10, 2026 | McAlevey Michael R Executive | Grant | Common Stock | $0 | +8K +240.09% | 11,859 <0.01% of shares | low |
| Feb 10, 2026 | Berres Jennifer Executive | Grant | Common Stock | $0 | +7K +46.17% | 22,528 0.01% of shares | low |
| Feb 10, 2026 | Wyatt Christopher F. Executive | Grant | Common Stock | $0 | +3K +7.27% | 49,413 0.02% of shares | low |
| Feb 10, 2026 | Cuffe Michael S. Executive | Grant | Common Stock | $0 | +10K +37.10% | 35,581 0.02% of shares | low |
| Feb 3, 2026 | Cuffe Michael S. Executive | Gift | Common Stock | $0 | -4K -13.50% | 25,953 0.01% of shares | low |
| Feb 10, 2026 | Foster Jon M Executive | Grant | Common Stock | $0 | +16K +118.42% | 28,950 0.01% of shares | low |
| Feb 6, 2026 | Hercules Holding II 10% owner | Other | Common Stock, par value $0.01 per share | $0 | -36.6M -53.15% | 32,282,889 14.91% of shares | low |
| Feb 10, 2026 | Hazen Samuel N CEO | Grant | Common Stock | $0 | +55K +175.90% | 86,165 0.04% of shares | low |
| Feb 6, 2026 | Frist Thomas F Jr 10% owner | Other | Common Stock, par value $0.01 per share | — | +36.6M | 36,557,141 16.89% of shares | low |
| Feb 6, 2026 | Frist Thomas F Jr 10% owner | Other | Common Stock, par value $0.01 per share | — | -36.6M -100.00% | 0 0.00% of shares | low |
| Jan 29, 2026 | Marks Mike A Executive | Grant | Stock Appreciation Right | — | +12K | 11,945 <0.01% of shares | low |
| Feb 13, 2026 | McAlevey Michael R Executive | Exercise | Stock Appreciation Right | — | -5K -36.08% | 8,860 <0.01% of shares | low |
| Jan 29, 2026 | McAlevey Michael R Executive | Grant | Stock Appreciation Right | — | +8K | 8,067 <0.01% of shares | low |